Importance of fibrinolysis in limiting thrombus formation following severe microarterial trauma: an experimental study in the rabbit.
In a blind randomized study, two groups of six rabbits were treated with either the fibrinolytic inhibitor tranexamic acid, 14 mg/kg bw, or isotonic saline solution (control group) given intraaortically as single bolus injections 5 min prior to arteriotomy and intimectomy of central ear arteries. Arteriotomic bleeding times, accumulations of 32P-labeled platelets, patency, and sizes of thrombus deposits 2 hr after reperfusion were recorded. Fixed vessels were observed by scanning electron microscopy. Bleeding times were similar in the two groups. The patency rate in the tranexamic acid group was 2/12, i.e., a significant reduction (P less than 0.05) from 7/12 in the control group. Thrombus deposits in occluded vessels contained large amounts of fibrin and red cells. Platelet accumulations in occluded vessels were significantly lower in the tranexamic acid group than in the control group, which indicates that the ratio of fibrin to platelets was increased in thrombi formed during antifibrinolytic treatment. This study has demonstrated the importance of normal fibrinolytic capacity in limiting thrombus formation following microarterial trauma. It is suggested that the use of antifibrinolytic agents in microvascular surgery should be restricted.
Arnljots
B
B
Department of Plastic and Reconstructive Surgery, Malmö General Hospital, Sweden.
Wieslander
J B
JB
Dougan
P
P
Salemark
L
L
D000818:Animals; D001158:Arteries / Q000601:surgery* / Q000648:ultrastructure; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D005342:Fibrinolysis / Q000187:drug effects / Q000502:physiology*; D008855:Microscopy, Electron, Scanning; D008866:Microsurgery; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D013927:Thrombosis / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D014148:Tranexamic Acid / Q000494:pharmacology*; D014654:Vascular Patency / Q000187:drug effects / Q000502:physiology; D014656:Vascular Surgical Procedures
D014148:Tranexamic Acid